Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-11-06
1993-03-09
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514384, 514824, A61K 3153, A61K 3141
Patent
active
051927616
ABSTRACT:
The invention provides pharmaceutical compositions comprising hypolipidemically active derivatives of 1,2,4-triazolidine-3,5-diones, 1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones, and 1,3,5-triazine-2,4(1H,3H)-diones in a pharmaceutically acceptable carrier for treating hyperlipidemia in mammals, particularly humans.
REFERENCES:
patent: 3663564 (1972-05-01), Jacobson et al.
patent: 4174392 (1979-11-01), Mohring et al.
patent: 4433085 (1984-02-01), Rottmaier et al.
patent: 4866058 (1989-09-01), Izydore et al.
Hall Iris H.
Izydore Robert A.
Jordan Kimberly R.
North Carolina Central Univ.
Smith Charles E.
University of North at Chapel Hill
Waddell Frederick E.
LandOfFree
1,2,4-triazolidine-3,5-diones and 1,3,5-triazine-2,4(1-H,3H)-dio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,4-triazolidine-3,5-diones and 1,3,5-triazine-2,4(1-H,3H)-dio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,4-triazolidine-3,5-diones and 1,3,5-triazine-2,4(1-H,3H)-dio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-211615